Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Full enrollment reached in phase II trial of CYT002-NicQb

Sep. 30, 2004

BPC-157 lessens effects of alcohol intoxication and withdrawal

Sep. 29, 2004

DOR BioPharma receives grant for ricin toxin vaccine work

Sep. 16, 2004

DigiFab submitted for approval in U.K.

Sep. 8, 2004

NRP-104 given fast track status for treating cocaine dependence

Sep. 3, 2004

Campral receives FDA approval

Aug. 3, 2004

Results of first phase III multicenter study of naltrexone depot formulation

July 22, 2004

Acamprosate does not affect alcohol pharmacokinetics and pharmacodynamics

July 21, 2004

Preliminary data on the effects and safety of TA-NIC in smokers

July 19, 2004

Combined drug therapy reduces cocaine use with limited abuse potential in primates

June 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...